Immunoassay Market
Immunoassay Market Size, Share & Trends Analysis Report by Product Type (Reagents & Kits, Analyzers/Instruments, and Software & Services), by Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FIA), Radioimmunoassay (RIA), Lateral Flow Immunoassay (LFIA), and Multiplex Immunoassay), by Application (Infectious Diseases, Oncology, Cardiology, Endocrinology, Autoimmune Diseases, Therapeutic Drug Monitoring (TDM), Allergy Testing, and Others), by End-User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Home Care, and Other), Forecast Period (2026–2035)
Industry Overview
Immunoassay market was valued at $37.6 billion in 2025 and is projected to reach $64.4 billion by 2035, growing at a CAGR of 5.6% during the forecast period (2026-2035). The market is expanding due to the rising demand for accurate and timely diagnostic solutions across healthcare settings. Increasing prevalence of chronic and infectious diseases has led to higher testing volumes and sustained utilization of immunoassay techniques. Advancements in assay sensitivity and automation have improved operational efficiency, encouraging wider adoption among laboratories. Growing emphasis on preventive healthcare and early disease detection has further supported consistent market demand. In addition, continued investments in healthcare infrastructure and diagnostic capabilities are reinforcing long-term growth prospects.
Market Dynamics
Rising Burden of Chronic and Infectious Conditions
The expansion of the immunoassay market is strongly supported by the increasing incidence of chronic and infectious diseases across major healthcare systems. Conditions such as cancer, cardiovascular disorders, and autoimmune diseases require early and accurate diagnostic tools, which has elevated the reliance on immunoassay-based testing. Public health programs and screening initiatives have further reinforced testing volumes, particularly in infectious disease surveillance and outbreak management. In addition, the shift toward preventive healthcare and routine diagnostics has improved test adoption rates in both urban and semi-urban healthcare settings. Healthcare providers are placing greater emphasis on rapid and reliable diagnostic outputs, which has encouraged investments in advanced immunoassay platforms. The integration of automated systems has also improved laboratory efficiency and turnaround times, strengthening demand at the institutional level. Furthermore, favorable reimbursement structures in developed healthcare systems continue to support test accessibility and volume growth.
Technological Advancements and Automation in Diagnostics
Continuous innovation in assay technologies and instrumentation has significantly influenced market expansion. Advancements such as chemiluminescence and multiplex platforms have enhanced sensitivity, specificity, and throughput, making them suitable for high-volume diagnostic environments. Laboratories are increasingly transitioning toward automated analyzers to reduce manual errors and optimize workflow efficiency. The incorporation of digital solutions and data management systems has further improved result interpretation and integration with hospital information systems. In parallel, the emergence of point-of-care testing formats has enabled decentralized diagnostics, particularly in resource-constrained settings. Manufacturers are focusing on developing compact, cost-efficient, and user-friendly systems to broaden accessibility. Strategic collaborations between diagnostic companies and healthcare providers are also accelerating product development and deployment. These factors collectively reinforce the role of immunoassays as a core component of modern diagnostic infrastructure.
Market Segmentation
- Based on product type, the market is segmented into reagents and kits, analyzers or instruments, and software and services.
- Based on technology, the market is segmented into enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA), and multiplex immunoassay.
- Based on application, the market is segmented into infectious diseases, oncology, cardiology, endocrinology, autoimmune diseases, therapeutic drug monitoring (TDM), allergy testing, and others.
- Based on end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, academic and research institutes, home care, and other end users.
Consistent Demand Anchor: Reagents and Kits Segment
The reagents and kits segment represents the largest share of the market, driven by their recurring consumption across diagnostic procedures. These products are essential for routine testing, leading to consistent demand irrespective of fluctuations in capital equipment purchases. Growth is supported by the increasing volume of diagnostic tests conducted in hospitals and laboratories. Manufacturers are focusing on developing highly specific and stable reagents to improve diagnostic accuracy and shelf life. The expansion of test menus, particularly in infectious disease and oncology diagnostics, has further strengthened this segment. Leading companies continue to invest in assay development to enhance compatibility with automated platforms and improve workflow efficiency.
Accelerated Adoption: Chemiluminescence Immunoassay (CLIA)
Chemiluminescence immunoassay is emerging as the fastest growing technology segment due to its superior sensitivity and ability to process large sample volumes. Laboratories are increasingly adopting CLIA systems to meet the growing demand for high-throughput testing with precise results. The technology is widely used in areas such as endocrinology, infectious diseases, and oncology diagnostics. Continuous improvements in analyzer design and assay performance have enhanced its clinical utility. Market participants are introducing integrated systems that combine automation with advanced detection capabilities, enabling faster turnaround times. The shift toward centralized laboratory testing and consolidation of diagnostic services has further accelerated the adoption of CLIA-based platforms.
Regional Outlook
The global immunoassay market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America: Established Infrastructure with Innovation Focus
North America maintains a strong position in the immunoassay market, supported by well-developed healthcare infrastructure and high diagnostic awareness. The region benefits from advanced laboratory networks and early adoption of innovative diagnostic technologies. Increasing demand for early disease detection and personalized treatment approaches continues to drive test volumes. Market participants are actively investing in research and development to introduce next-generation immunoassay solutions. The presence of leading diagnostic companies further strengthens competitive intensity and technological progress. Additionally, favorable reimbursement frameworks contribute to sustained utilization of advanced diagnostic tests.
Asia-Pacific: Expanding Access and Diagnostic Capacity
Asia-Pacific is witnessing notable growth due to improving healthcare access and rising investments in diagnostic infrastructure. Rapid urbanization and increasing healthcare expenditure have enhanced the availability of diagnostic services across emerging economies. Governments are focusing on strengthening disease surveillance systems and expanding laboratory capabilities. The growing burden of infectious and lifestyle-related diseases has significantly increased the demand for immunoassay testing. Local and international players are expanding their presence through partnerships and distribution networks. Moreover, the adoption of cost-effective and portable diagnostic solutions is supporting market penetration in semi-urban and rural areas.
Market Players Outlook
The major companies operating in the global immunoassaymarket include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In January 2025, Anbio Biotechnology introduced its dry chemiluminescence immunoassay (CLIA) solution ADL-100, designed to deliver rapid and cost-efficient diagnostic results across varied clinical settings.
- In July 2023, Lumos Diagnostics received regulatory approval for its FebriDx immunoassay test, enabling broader commercialization through distribution partnerships and expanding its reach in point-of-care diagnostics.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global immunoassay market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Global Immunoassay Market Sales Analysis – Product Type | Technology |
Application | End-User ($ Million)
• Immunoassay Market Sales Performance of Top Countries
1.1 Research Methodology
• Primary Research Approach
• Secondary Research Approach
1.2 Market Snapshot
2. Market Overview and Insights
2.1 Scope of the Study
2.2 Analyst Insight & Current Market Trends
2.2.1 Key Immunoassay Market Trends
2.2.2 Market Recommendations
2.3 Porter's Five Forces Analysis for
the Immunoassay Market
2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes
3. Market Determinants
3.1 Market Drivers
3.1.1 Drivers For Global Immunoassay Market: Impact Analysis
3.2 Market Pain Points and Challenges
3.2.1 Restraints For Global Immunoassay Market: Impact Analysis
3.3 Market Opportunities
3.3.1 Opportunities For Global Immunoassay Market: Impact Analysis
4. Competitive Landscape
4.1 Competitive Dashboard – Immunoassay Market Revenue and Share by
Manufacturers
• Immunoassay Product Comparison Analysis
• Top Market Player Ranking Matrix
4.2 Key Company Analysis
4.2.1 Abbott Laboratories
4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Financial Analysis
4.2.1.4 SWOT Analysis
4.2.1.5 Business Strategy
4.2.2 F. Hoffmann-La Roche Ltd
4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Financial Analysis
4.2.2.4 SWOT Analysis
4.2.2.5 Business Strategy
4.2.3 Siemens Healthineers AG
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Financial Analysis
4.2.3.4 SWOT Analysis
4.2.3.5 Business Strategy
4.2.4 Danaher Corporation
4.2.4.1 Overview
4.2.4.2 Product Portfolio
4.2.4.3 Financial Analysis
4.2.4.4 SWOT Analysis
4.2.4.5 Business Strategy
4.2.5 Thermo Fisher Scientific Inc.
4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Financial Analysis
4.2.5.4 SWOT Analysis
4.2.5.5 Business Strategy
4.3 Top Winning Strategies by Market
Players
4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership And Collaboration
5. Global Immunoassay Market Sales
Analysis by Product Type ($ Million)
5.1 Reagents & Kits
5.2 Analyzers/Instruments
5.3 Software & Services
6. Global Immunoassay Market Sales
Analysis by Technology ($ Million)
6.1 Enzyme-Linked Immunosorbent Assay (ELISA)
6.2 Chemiluminescence Immunoassay (CLIA)
6.3 Fluorescence Immunoassay (FIA)
6.4 Radioimmunoassay (RIA)
6.5 Lateral Flow Immunoassay (LFIA)
6.6 Multiplex Immunoassay
7. Global Immunoassay Market Sales
Analysis by Application ($ Million)
7.1 Infectious Diseases
7.2 Oncology
7.3 Cardiology
7.4 Endocrinology
7.5 Autoimmune Diseases
7.6 Therapeutic Drug Monitoring (TDM)
7.7 Allergy Testing
7.8 Others
8. Global Immunoassay Market Sales
Analysis by End-User ($ Million)
8.1 Hospitals & Clinics
8.2 Diagnostic Laboratories
8.3 Academic & Research Institutes
8.4 Home Care
8.5 Other
9. Regional Analysis
9.1 North American Immunoassay Market Sales
Analysis – Product Type | Technology | Application | End-User | Country ($
Million)
9.1.1 United States
9.1.2 Canada
9.2 European Immunoassay Market Sales
Analysis – Product Type | Technology | Application | End-User | Country ($
Million)
9.2.1 UK
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 France
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia-Pacific Immunoassay Market Sales
Analysis – Product Type | Technology | Application | End-User | Country ($
Million)
9.3.1 China
9.3.2 Japan
9.3.3 South Korea
9.3.4 India
9.3.5 Australia & New Zealand
9.3.6 ASEAN Countries
9.3.7 Rest of Asia-Pacific
9.4 Rest of the World Immunoassay Market
Sales Analysis – Product Type | Technology | Application | End-User | Country
($ Million)
9.4.1 Latin America
9.4.2 Middle East and Africa
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Quick Facts
10.1.2 Company Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.2 Agilent Technologies
10.2.1 Quick Facts
10.2.2 Company Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.3 Becton, Dickinson and Company
10.4 Bio-Rad Laboratories
10.5 bioMérieux SA
10.6 Danaher Corporation
10.7 DiaSorin S.p.A.
10.8 Eiaab Science
10.9 F. Hoffmann-La Roche Ltd
10.10 Fujirebio Holdings Inc.
10.11 Grifols S.A.
10.12 Horiba, Ltd.
10.13 Menarini Diagnostics S.r.l.
10.14 Merck KGaA
10.15 PerkinElmer Inc.
10.16 QuidelOrtho Corporation
10.17 Randox Laboratories Ltd.
10.18 Roche Diagnostics International Ltd
10.19 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
10.20 Siemens Healthineers AG
10.21 Snibe Co., Ltd.
10.22 Sysmex Corporation
10.23 Thermo Fisher Scientific Inc.
10.24 Tosoh Corporation
10.25 Werfen S.A.
1 Global Immunoassay Market Research and Analysis by Product Type, 2025–2035 ($ Million)
2 Global Reagents & Kits Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
3 Global Analyzers/Instruments Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
4 Global Software & Services Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
5 Global Immunoassay Market Research and Analysis by Technology, 2025–2035 ($ Million)
6 Global ELISA Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
7 Global CLIA Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
8 Global FIA Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
9 Global RIA Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
10 Global LFIA Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
11 Global Multiplex Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
12 Global Immunoassay Market Research and Analysis by Application, 2025–2035 ($ Million)
13 Global Immunoassay for Infectious Diseases Market Research and Analysis by Region, 2025–2035 ($ Million)
14 Global Immunoassay for Oncology Market Research and Analysis by Region, 2025–2035 ($ Million)
15 Global Immunoassay for Cardiology Market Research and Analysis by Region, 2025–2035 ($ Million)
16 Global Immunoassay for Endocrinology Market Research and Analysis by Region, 2025–2035 ($ Million)
17 Global Immunoassay for Autoimmune Diseases Market Research and Analysis by Region, 2025–2035 ($ Million)
18 Global Immunoassay for Therapeutic Drug Monitoring (TDM) Market Research and Analysis by Region, 2025–2035 ($ Million)
19 Global Immunoassay for Allergy Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
20 Global Immunoassay for Others Market Research and Analysis by Region, 2025–2035 ($ Million)
21 Global Immunoassay Market Research and Analysis by End-User, 2025–2035 ($ Million)
22 Global Immunoassay for Hospitals & Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
23 Global Immunoassay for Diagnostic Laboratories Market Research and Analysis by Region, 2025–2035 ($ Million)
24 Global Immunoassay for Academic & Research Institutes Market Research and Analysis by Region, 2025–2035 ($ Million)
25 Global Immunoassay for Home Care Market Research and Analysis by Region, 2025–2035 ($ Million)
26 Global Immunoassay for Other Market Research and Analysis by Region, 2025–2035 ($ Million)
27 Global Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
28 North America Immunoassay Market Research and Analysis by Country, 2025–2035 ($ Million)
29 North America Immunoassay Market Research and Analysis by Product Type, 2025–2035 ($ Million)
30 North America Immunoassay Market Research and Analysis by Technology, 2025–2035 ($ Million)
31 North America Immunoassay Market Research and Analysis by Application, 2025–2035 ($ Million)
32 North America Immunoassay Market Research and Analysis by End-User, 2025–2035 ($ Million)
33 Europe Immunoassay Market Research and Analysis by Country, 2025–2035 ($ Million)
34 Europe Immunoassay Market Research and Analysis by Product Type, 2025–2035 ($ Million)
35 Europe Immunoassay Market Research and Analysis by Technology, 2025–2035 ($ Million)
36 Europe Immunoassay Market Research and Analysis by Application, 2025–2035 ($ Million)
37 Europe Immunoassay Market Research and Analysis by End-User, 2025–2035 ($ Million)
38 Asia-Pacific Immunoassay Market Research and Analysis by Country, 2025–2035 ($ Million)
39 Asia-Pacific Immunoassay Market Research and Analysis by Product Type, 2025–2035 ($ Million)
40 Asia-Pacific Immunoassay Market Research and Analysis by Technology, 2025–2035 ($ Million)
41 Asia-Pacific Immunoassay Market Research and Analysis by Application, 2025–2035 ($ Million)
42 Asia-Pacific Immunoassay Market Research and Analysis by End-User, 2025–2035 ($ Million)
43 Rest of the World Immunoassay Market Research and Analysis by Region, 2025–2035 ($ Million)
44 Rest of the World Immunoassay Market Research and Analysis by Product Type, 2025–2035 ($ Million)
45 Rest of the World Immunoassay Market Research and Analysis by Technology, 2025–2035 ($ Million)
46 Rest of the World Immunoassay Market Research and Analysis by Application, 2025–2035 ($ Million)
47 Rest of the World Immunoassay Market Research and Analysis by End-User, 2025–2035 ($ Million)
1 Global Immunoassay Market Share by Segment, 2025 Vs 2035 (%)
2 Global Reagents & Kits Immunoassay Market Share by Region, 2025 Vs 2035 (%)
3 Global Analyzers/Instruments Immunoassay Market Share by Region, 2025 Vs 2035 (%)
4 Global Software & Services Immunoassay Market Share by Region, 2025 Vs 2035 (%)
5 Global ELISA Immunoassay Market Share by Region, 2025 Vs 2035 (%)
6 Global CLIA Immunoassay Market Share by Region, 2025 Vs 2035 (%)
7 Global FIA Immunoassay Market Share by Region, 2025 Vs 2035 (%)
8 Global RIA Immunoassay Market Share by Region, 2025 Vs 2035 (%)
9 Global LFIA Immunoassay Market Share by Region, 2025 Vs 2035 (%)
10 Global Multiplex Immunoassay Market Share by Region, 2025 Vs 2035 (%)
11 Global Immunoassay for Infectious Diseases Market Share by Region, 2025 Vs 2035 (%)
12 Global Immunoassay for Oncology Market Share by Region, 2025 Vs 2035 (%)
13 Global Immunoassay for Cardiology Market Share by Region, 2025 Vs 2035 (%)
14 Global Immunoassay for Endocrinology Market Share by Region, 2025 Vs 2035 (%)
15 Global Immunoassay for Autoimmune Diseases Market Share by Region, 2025 Vs 2035 (%)
16 Global Immunoassay for Therapeutic Drug Monitoring (TDM) Market Share by Region, 2025 Vs 2035 (%)
17 Global Immunoassay for Allergy Testing Market Share by Region, 2025 Vs 2035 (%)
18 Global Immunoassay for Others Market Share by Region, 2025 Vs 2035 (%)
19 Global Immunoassay for Hospitals & Clinics Market Share by Region, 2025 Vs 2035 (%)
20 Global Immunoassay for Diagnostic Laboratories Market Share by Region, 2025 Vs 2035 (%)
21 Global Immunoassay for Academic & Research Institutes Market Share by Region, 2025 Vs 2035 (%)
22 Global Immunoassay for Home Care Market Share by Region, 2025 Vs 2035 (%)
23 Global Immunoassay for Other Market Share by Region, 2025 Vs 2035 (%)
24 Global Immunoassay Market Share by Region, 2025 Vs 2035 (%)
25 United States Immunoassay Market Size, 2025-2035 ($ Million)
26 Canada Immunoassay Market Size, 2025-2035 ($ Million)
27 UK Immunoassay Market Size, 2025-2035 ($ Million)
28 France Immunoassay Market Size, 2025-2035 ($ Million)
29 Germany Immunoassay Market Size, 2025-2035 ($ Million)
30 Italy Immunoassay Market Size, 2025-2035 ($ Million)
31 Spain Immunoassay Market Size, 2025-2035 ($ Million)
32 Russia Immunoassay Market Size, 2025-2035 ($ Million)
33 India Immunoassay Market Size, 2025-2035 ($ Million)
34 China Immunoassay Market Size, 2025-2035 ($ Million)
35 Japan Immunoassay Market Size, 2025-2035 ($ Million)
36 South Korea Immunoassay Market Size, 2025-2035 ($ Million)
37 Australia & New Zealand Immunoassay Market Size, 2025-2035 ($ Million)
38 ASEAN Immunoassay Market Size, 2025-2035 ($ Million)
39 Rest of Asia-Pacific Immunoassay Market Size, 2025-2035 ($ Million)
40 Latin America Immunoassay Market Size, 2025-2035 ($ Million)
41 Middle East & Africa Immunoassay Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
